Your session is about to expire
← Back to Search
Ketamine for Acute Pain
Study Summary
This trial is studying whether a longer or shorter infusion of ketamine reduces side effects in people with severe pain in the emergency department.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I experience pain in my abdomen, back, sides, muscles, or chest due to injury.I regularly use strong painkillers like fentanyl.I haven't used fentanyl in the last hour or other painkillers in the last 4 hours.I have a history of serious heart problems.My liver or kidneys are not working properly.I am currently experiencing a manic episode.You currently experience strong beliefs or see or hear things that are not real, or have been diagnosed with schizophrenia.My pain level is at least a 5 out of 10.I am fully aware of who I am, where I am, and the current time.I have a thyroid condition that hasn't been treated or controlled.I have recently had a head or eye injury.Your blood pressure, heart rate, or breathing is not within the normal range.I have been diagnosed with high pressure in my brain.You have already participated in this study during a previous visit to the emergency department.You are currently using alcohol or drugs.Changes in your thinking and behavior.You have a known allergy or bad reaction to ketamine.I am 18 years old or older.
- Group 1: Ketamine 15 Minutes
- Group 2: Ketamine 30 Minutes
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA certified Ketamine for medicinal use?
"There is ample evidence in favor of Ketamine's safety, thus it has earned a rating of 3."
May I be considered for participation in this scientific experiment?
"This clinical trial seeks 48 participants aged 18 to 65 who suffer from acute pain. Those wishing to participate should meet the following conditions: present a VAS/ numeric pain scale score of at least 5cm (50mm), have symptoms localized in the abdominal, flank, back, musculoskeletal or traumatic chest areas, be mentally lucid and able to provide consent."
Does this investigation accept participants over the age of 50?
"Eligibility for this clinical trial necessitates a patient to be within the ages of 18 and 65. There are 60 investigations available to minors while older participants can join 281 studies."
Are there any spots available for this investigation at present?
"According to clinicaltrials.gov, this medical trial is not presently looking for more patients. The study's initial posting was on November 15th 2022 and its most recent modification occurred on September 24th 2022. During this period of inactivity, there are 346 other trials actively seeking participants."
Share this study with friends
Copy Link
Messenger